Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Rosuvastatin Treatment for prEventing coMplIcationS In Renal Ablation

NCT01899027 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT01899027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01899027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Rosuvastatin Treatment for prEventing coMplIcationS In Renal Ablation
Lead sponsor
University of Roma La Sapienza
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2017
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension